Cocrystal Pharma (COCP) Other Operating Expenses (2010 - 2023)

Cocrystal Pharma (COCP) posted Other Operating Expenses of -$1.0 million for Q4 2023, up 37.5% sequentially from -$1.6 million in Q3 2023.

Cocrystal Pharma (COCP) Other Operating Expenses (2010 - 2023) Analysis & Trends

Cocrystal Pharma has reported Other Operating Expenses for 9 years, with the latest figure at -$1.0 million in Q4 2023.

Quarterly Other Operating Expenses changed N/A year-over-year to -$1.0 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$1.0 million (up 37.5% YoY) and the FY2023 annual result came in at -$2.6 million, down 112.57% from the prior year.
Other Operating Expenses grew to -$1.0 million in Q4 2023 per COCP's latest filing, from -$1.6 million in the prior quarter.
Over five years, Other Operating Expenses peaked at $46.1 million in Q4 2019 and troughed at -$1.6 million in Q3 2023.
A 3-year average of $16.0 million and a median of $9.8 million in 2022 frame the typical range for Other Operating Expenses.
The widest YoY moves for Other Operating Expenses: up 4610200.0% in 2019, down 4610200.0% in 2019.
Over 3 years, Other Operating Expenses stood at $46.1 million in 2019, then sank by 55.12% to $20.7 million in 2022, then plunged by 104.83% to -$1.0 million in 2023.
According to Business Quant data, Other Operating Expenses over the past three periods registered -$1.0 million, -$1.6 million, and $20.7 million for Q4 2023, Q3 2023, and Q2 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Cocrystal Pharma	15.65 Mn	13.33 Mn	-

Download Data